Sirtuin-dependent protein deacetylase activation
Sirtuin Activation (STACs) · Metabolic sensing, autophagy and longevity
Activates SIRT1-7 deacetylases through an allosteric conformational change or by supplying NAD+ substrate. It regulates histones, FOXO and p53 to promote DNA damage repair and cell survival.
Supplements acting on this mechanism (ranked by strength and evidence)
NMN (nicotinamide mononucleotide)
NAD+ is an essential co-substrate for sirtuin deacetylation reactions, so higher NAD+ is in theory beneficial for sirtuin activity. However, supplying a precursor does not necessarily raise enzyme activity. A mouse study observed SIRT3-dependent protein deacetylation, but direct evidence after oral NMN in humans is still lacking.
Nicotinamide riboside (NR)
The NAD+ supplied by NR is an essential substrate for sirtuin reactions. In theory it could drive SIRT3 deacetylation, which in turn activates the mitochondrial antioxidant enzyme SOD2. This chain comes mainly from animal and cell studies. Higher blood NAD+ in humans does not prove that SIRT3 activity in tissues rose at the same time.
Pterostilbene
In animal models, pterostilbene restored SIRT1 deacetylation activity and related rhythms. Whether it binds SIRT1 directly and activates it allosterically remains disputed, and upregulation of anti-aging genes has not been confirmed in humans.
Trans-resveratrol
Direct allosteric activation of SIRT1 varies with the substrate used in testing, and the conclusions remain disputed. SIRT1 protein can increase in humans, but more protein does not mean higher enzyme activity. Evidence for indirect effects, such as those through phosphodiesterase inhibition, is also insufficient at usual doses in humans.
Melatonin (biphasic immediate/extended release)
Higher doses of melatonin can increase hippocampal SIRT1 expression in aged mice, but increased expression does not mean direct activation of the deacetylase. This experimental dose is higher than usual human doses, and the related mechanism has not been established in humans.
Quercetin
Animal models suggest quercetin may modulate SIRT1 indirectly. The claim that it directly activates SIRT1 allosterically is disputed because the results depend on the assay method and substrate. Its effect at usual human doses has not been confirmed.